Public scrutiny of Purdue Pharma’s role in the opioid crisis increased sharply in the years after the state of Kentucky filed a lawsuit against the company. New research from David Tan, University of Washington associate professor of management, examines the ensuing behavior of competing prescription opioid companies.
